Dermatology: Practical and Conceptual


Dermatology Practical & Conceptual

Commentary  |  Dermatol Pract Concept. 2021;11(3):e2021080 1

Solidarity and Voluntarism Amid the COVID-19 
Pandemic: Skin Cancer Screening for Blood Donors 

Katerina Grafanaki1, Sophia Georgiou1, Alexander J. Stratigos2

1 Department of Dermatology, University Hospital of Patras, School of Medicine, University of Patras, Greece

2 Department of Dermatology-Venereology, Andreas Syggros Hospital, National and Kapodestrian University of Athens, Greece

Key words: skin cancer screening, volunteer blood donors, teledermatology, Red Cross, public health, solidarity

Citation: Grafanaki K, Georgiou S, Stratigos AJ. Solidarity and voluntarism amid the COVID-19 pandemic: skin cancer screening for 
volunteer blood donors. Dermatol Pract Concept. 2021;11(3):e2021080. DOI: https://doi.org/10.5826/dpc.1103a80

Accepted: February 5, 2021 Published: May 20, 2021

Copyright: ©2021 Grafanaki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 
BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors 
and source are credited.

Funding: None.

Competing interests: The authors have no conflicts of interest to disclose.

Authorship: All authors have contributed significantly to this publication.

Corresponding Author: Katerina Grafanaki MSc, MD, PhD, Department of Dermatology, University Hospital of Patras, School of 
Medicine, University of Patras, 26504 Patras, Greece. Email: grafanaki@med.upatras.gr

Melanoma is the deadliest skin cancer, and its incidence is 

increasing globally. It is preventable, and indeed increased 

sun awareness campaigns and early diagnoses through skin 

cancer screening programs for the general population have 

contributed to decreasing mortality from melanoma. Many of 

the volunteer activities involved in raising public awareness 

about melanoma are provided by dermatological societies 

and volunteer dermatologists who are often not sufficiently 

credited for their contributions.  The recipients of these free 

services include blood donors and emergency service provid-

ers (eg, Hellenic Red Cross Samaritans). 

Although efforts over the past decade have led to a sig-

nificant reduction in skin cancer, activities have been sus-

pended and, in many cases, disrupted since the outbreak 

of coronavirus disease 2019 (COVID-19) created a public 

health emergency of international concern. National health 

systems are overburdened, and patients are avoiding specialist 

visits due to fears of becoming infected with the SARS-CoV-2 

virus while attending a medical clinic. As a result, a 68.61% 

reduction in skin cancer diagnoses has been reported in the 

UK [1]. During the strict government measures to contain 

the spread of SARS-CoV-2 and minimized the number of 

COVID-19 cases, dermatologists have limited their activities 

to dermatological emergencies and have opted to practice 

teledermatology for less urgent issues. 

Concurrently, another major disruption due to the 

COVID-19 pandemic is a shortage of blood for transfusions. 

Every 2 seconds, a patient in the United States needs a red 

blood cell transfusion; almost 5,000 platelet units and 6,500 

units of plasma are required daily. Plasma containing anti-

bodies against SARS-CoV-2 could be transfused into severely 

ill patients with COVID-19 [2]. Importantly, lack of ethnic 

diversity within the donor pool and rare blood types should 

be acknowledged [3]. During the pandemic, 86,000 American 

Red Cross (ARC) blood drives were cancelled, whereas in 

Europe and Asia blood banks continue to play a vital role in 

ensuring an uninterrupted supply of blood and blood compo-

nents [3]. An opportunity to donate is an opportunity to save 

a life. The ARC is offering free SARS-CoV-2 antibody testing 

to blood donors [2]. The International Federation of the Red 



2 Commentary  |  Dermatol Pract Concept. 2021;11(3):e2021080

Cross is an impartial, neutral, and independent organization 

whose mission is to assist in the response to humanitarian 

emergencies such as epidemics [3]. 

Since 1985, the American Academy of Dermatology has 

been offering free skin cancer screening. Volunteer derma-

tologists have performed more than 2.8 million screenings 

and detected more than 31,500 suspected melanomas and 

278,000 suspicious lesions, saving countless lives [4]. Skin 

Cancer Awareness Month (United States), Euromelanoma 

(Europe), and similar campaigns on other continents, which 

have a significant impact on early diagnosis of melanoma, 

were either mostly realized via internet and were mass 

media-based or were cancelled, depending on the country’s 

restrictions. While the pandemic may represent a threat to 

many aspects of our existence, dermatologists can show a 

humanitarian face through voluntary skin cancer screening 

of life-saving volunteer blood donors. 

Early detection of melanoma is facilitated by telederma-

tology using smartphones [5] and teledermoscopy [6]. These 

tools increase dermatological access in rural regions and 

contribute to gender, racial and ethnic equity [7], especially 

in heterogeneous socioeconomic groups such as blood donors 

who would otherwise not seek a dermatologist during these 

times. Virtual melanoma checks, with 94% diagnostic accu-

racy [8], could eliminate the risk of contracting COVID-19.  

Patients with potentially malignant lesions can be diagnosed 

and biopsied. The limitation due to the number of high-risk 

blood donors to be screened could be overcome through 

careful selection by a pre-screening questionnaire considering 

their age, phototype, and familial, personal and sun exposure 

histories.  For example, people who volunteer as lifeguards, 

a profession with high sun exposure, could be prioritized. 

Teledermatology could be delivered using either store-and-

forward or real-time video technology, or a hybrid of both [9].

“In the presence of epidemics or other danger, I will not 

allow fear of personal harm to turn me from my duty,” says 

the Hippocratic Oath. Most of us have not worked through 

pandemics before, but it is time to embrace humanity and 

solidarity. Volunteering motivation is important in forming a 

person’s decision to contribute their time and effort without 

expecting financial rewards. In a time of deep economic crisis, 

unemployment and social exclusion, solidarity and non-profit 

assistance to fellow human beings is an urgent need of both 

the state and society. Amid the ongoing pandemic, blood 

donations and skin cancer screening must not be disrupted; 

they can be continued as long as attention is foremost paid 

to patient safety.

Supporting volunteer blood donors through voluntary 

skin cancer screening could be an excellent initiative, bringing 

people together, giving us the opportunity to abandon the 

illusion of power and admit our weakness to the ongoing 

pandemic. Only with humility, solidarity, and insight can we 

accomplish sustainability despite the challenges. Skin cancer 

screening of volunteer blood donors could be a high-impact 

skin cancer prevention initiative, rewarding and motivating 

for volunteers. The volunteer dermatologist may feel fulfill-

ment from wiping out preventable skin cancer.  The blood 

donor will be motivated and encouraged to continue with 

their life-saving donations. 

In light of a change in dermatology practice, investing in 

prevention strategies in public health and social protection 

is the mark of a responsible action policy. The COVID-19 

pandemic is probably here to stay and is delaying preventive 

skin cancer diagnosis and treatment that our health system 

will struggle to cover. Perhaps this is the impetus to mobilize 

and do something useful and lifesaving during this public 

health emergency.

References

1. Andrew TW, Alrawi M, Lovat P. Reduction in skin cancer di-

agnoses in the UK during the COVID-19 pandemic. Clin Exp 

Dermatol. 2020;46(1):145-146. DOI: 10.1111/ced.14411. PMID: 

32754962.

2. Sen-Crowe B, McKenney K, McKenney M, Elkbuli A. Challenges 

associated with blood banks and blood donations during the 

COVID-19 pandemic. Am J Emerg Med. 2020;20: 30546-5. DOI: 

10.1016/j.cll.2020.08.013. PMID: 32674923.

3. International Federation of the Red Cross (IFRC) Voluntary blood 

donation. Accessed November 28, 2020. https://media.ifrc.org/

ifrc/what-we-do/health/voluntary-blood-donation/

4. American Academy of Dermatology Association. Free skin cancer 

screenings. Accessed November 28, 2020.  https://www.aad.org/

public/public-health/skin-cancer-screenings  

5. Malhi IS, Yiu ZZN. Algorithm-based smartphone apps to assess 

risk of skin cancer in adults: critical appraisal of a systematic 

review. Br J Dermatol. 2020 Aug 31. DOI: 10.1111/bjd.19502. 

PMID: 32866990.

6. Tognetti L, Cevenini G, Moscarella E, et al. Validation of an 

integrated dermoscopic scoring method in a European teleder-

moscopy web platform: the iDScore project for early detection of 

melanoma. J Eur Acad Dermatol Venereol. 2020;34(3):640-647. 

DOI: 10.1111/jdv.15923. PMID: 31465600.

7. Hadeler EK, Beer J Nouri K. Teledermatology: improving access 

or widening healthcare disparities? 2020;19(12):1248. DOI: 

10.36849/JDD.2020.5693. PMID: 33346507. 

8. Massone C, Maak D, Hofmann-Wellenhof R, Soyer HP, Frühauf 

J. Teledermatology for skin cancer prevention: an experience 

on 690 Austrian patients. J Eur Acad Dermatol Venereol. 

2014;28(8):1103-1108. DOI: DOI: 10.1111/jdv.12351. PMID: 

24372877.

9. Kazi R, Evankovich MR, Liu R, et al. Utilization of asynchronous 

and synchronous teledermatology in a large health care system 

during the COVID-19 pandemic. Telemed J E Health. 2020 Oct 

19. DOI: 10.1089/tmj.2020.0299. PMID: 33074786.